Statin May Cut GVHD in Stem-Cell Recipients (CME/CE)

(MedPage Today) -- Stem-cell transplant recipients had low rates of acute graft-versus-host disease (GVHD) with a conditioning regimen that included lipid-lowering agent atorvastatin, a preliminary study showed.
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news